The margins improved in both business areas in line with our priorities and initiatives. The debt level continued to decrease, and we have achieved our ambition to lower the net debt in relation to EBITDA to below 3.0. AddLife is now ready to gradually increase acquisition activity, and at the beginning of April, the acquisition of Edge Medical was completed.
We strive to improve people's lives
Interim Report Q1 2025
2702
NET SALES, SEKm
343
EBITA, SEKm
12.7
%
EBITA MARGIN
53
%
P/WC
Margin improvement continues, the debt level is reduced, and acquisition activity increases
A leading partner in Life Science
AddLife is a leading independent European partner with a diversified portfolio in Life Science. AddLife owns, develops and acquires market-leading companies in specific segments with offerings aimed primarily at the healthcare sector – from research to medical care. The Group has a rooted, entrepreneur-driven culture with strong values, where sustainability is integrated into the business.
30
COUNTRIES
2300
EMPLOYEES
54000
CUSTOMERS
3500
SUPPLIERS
Labtech
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.
Medtech
In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment and digital solutions for home care. Medtech has two business units, Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.
AddLife and sustainability
AddLife's
sustainability
strategy
sustainability
strategy
Sustainable solutions
for health
for health
Sustainable culture
Sustainable supply chain
AddLife's sustainability strategy
AddLife’s sustainability report describes the business operations and value chain from a sustainability perspective. The sustainability strategy mirrors our key sustainability issues: our positive contribution to the Life Science sector, the well-being and development of our employees, and our work with supply chain management.
Sustainable solutions for health
AddLife creates competitive advantages by offering high-quality products and value-creating services, combined with environmentally smart solutions. This is a unique opportunity to support a sustainable transition together with the Group’s partners and develop solutions that can also positively impact business operations.
Sustainable culture
AddLife’s employees' engagement is key to the Group’s success. AddLife strives to create an inclusive organization for its talented and engaged colleagues, characterized by diversity. To achieve this, the Group focuses on issues related to corporate culture, employee satisfaction, diversity, and inclusion.
Sustainable supply chain
AddLife is committed to environmental and social issues throughout the supply chain. This work involves evaluating, communicating with, and influencing AddLife’s suppliers, as well as identifying new market-leading alternatives. AddLife’s role in the value chain provides the Group with an opportunity to develop solutions together with its partners to take responsibility for the Group’s overall impact.
AddLife creates value
AddLife aims to create good earnings and a strong shareholder value through independent subsidiaries, active ownership and acquisitions. AddLife's financial targets contribute to a robust cash flow that facilitates self-financed, long-term and profitable growth.
Four reasons to own shares in AddLife
Attractive growth market
Cash flow finances growth
Clear strategy
Market position
Attractive non-cyclical growth market
The market, in which AddLife operates, is relatively insensitive to cyclical fluctuations and is driven by demographic factors, an ageing population and the increasing prevalence of chronic diseases. On average, the medtech market is expected to achieve an annual growth rate of 5 percent and the diagnostics market 2-3 percent.
Cash flow finances growth
AddLife strives for profitable organic growth and has a high proportion of recurring sales and long-term contracts that generate stable cash flows. The company bases its acquisition agenda on financing acquisitions through its own cash flow.
Clear strategy to create additional growth
A key element of AddLife's growth strategy is acquisitions, with a focus on small and mid-sized bolt-on acquisitions or standalone acquisitions with attractive margins. The goal is for the acquired subsidiaries to continue to develop based on their strengths, based in a decentralised business model.
Strong market position in Europe
AddLife’s more than 85 subsidiaries create value and build leading positions in selected niches in Europe. The company has a wide geographic spread, operating in 30 countries with 2,300 employees.
